• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Management of paronychia with pseudopyogenic granulomas secondary to epidermal growth factor receptor inhibitors: An assessment of topical timolol and the need for multiple medical and procedural therapies.

作者信息

Olamiju Brianna, Bhullar Shaman, Coleman Emily L, Leventhal Jonathan S

机构信息

Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut.

Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut.

出版信息

J Am Acad Dermatol. 2021 Mar;84(3):806-808. doi: 10.1016/j.jaad.2020.06.010. Epub 2020 Jun 11.

DOI:10.1016/j.jaad.2020.06.010
PMID:32526318
Abstract
摘要

相似文献

1
Management of paronychia with pseudopyogenic granulomas secondary to epidermal growth factor receptor inhibitors: An assessment of topical timolol and the need for multiple medical and procedural therapies.表皮生长因子受体抑制剂继发假性化脓性肉芽肿性甲沟炎的管理：噻吗洛尔局部应用的评估及多种药物和手术治疗的必要性
J Am Acad Dermatol. 2021 Mar;84(3):806-808. doi: 10.1016/j.jaad.2020.06.010. Epub 2020 Jun 11.
2
Topical Timolol for Paronychia and Pseudopyogenic Granuloma in Patients Treated With Epidermal Growth Factor Receptor Inhibitors and Capecitabine.表皮生长因子受体抑制剂和卡培他滨治疗患者的甲旁和假脓性肉芽肿痛局部用噻吗洛尔治疗。
JAMA Dermatol. 2018 Jan 1;154(1):99-100. doi: 10.1001/jamadermatol.2017.4120.
3
Combination of available topical beta-blockers and antibiotic ointment for epidermal growth factor receptor tyrosine kinase inhibitor-induced paronychia and pseudopyogenic granulomas in Taiwan.台湾地区表皮生长因子受体酪氨酸激酶抑制剂诱导的甲沟炎和假脓性肉芽肿中，局部应用β受体阻滞剂与抗生素软膏联合治疗。
J Oncol Pharm Pract. 2023 Sep;29(6):1374-1380. doi: 10.1177/10781552221122051. Epub 2022 Sep 15.
4
Recalcitrant trametinib-induced paronychia treated successfully with topical timolol in a pediatric patient.难治性曲美替尼诱导的甲沟炎经局部噻吗洛尔治疗成功在儿科患者。
Dermatol Ther. 2020 Jan;33(1):e13164. doi: 10.1111/dth.13164. Epub 2019 Nov 15.
5
Development of multiple paronychia and periungual granulation in patients treated with gefitinib, an inhibitor of epidermal growth factor receptor.
Dermatology. 2003;207(3):324-5. doi: 10.1159/000073100.
6
Skin Toxicities Induced by Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors and their Influence on Treatment Adjustments in Lung Cancer Patients.表皮生长因子受体酪氨酸激酶抑制剂引起的皮肤毒性及其对肺癌患者治疗调整的影响。
Acta Derm Venereol. 2024 Aug 28;104:adv40555. doi: 10.2340/actadv.v104.40555.
7
Treatment of epidermal growth factor receptor inhibitor-induced severe paronychia with pyogenic granuloma-like lesions with topical betaxolol: an open-label observation study.外用倍他洛尔治疗表皮生长因子受体抑制剂相关严重甲周脓皮病伴化脓性肉芽肿样损害：一项开放性观察研究。
Int J Dermatol. 2020 Mar;59(3):326-332. doi: 10.1111/ijd.14730. Epub 2019 Nov 25.
8
Are topical beta-blockers really effective "in real life" for targeted therapy-induced paronychia.局部使用β受体阻滞剂在靶向治疗诱导性甲周炎的“真实生活”中真的有效吗？
Support Care Cancer. 2019 Jul;27(7):2341-2343. doi: 10.1007/s00520-019-04690-8. Epub 2019 Mar 7.
9
Successful management of angiolymphoid hyperplasia with eosinophilia in a split-face trial of topical tacrolimus and timolol solution.在一项外用他克莫司和噻吗洛尔溶液的半脸试验中对嗜酸性粒细胞增多性血管淋巴样增生的成功管理。
G Ital Dermatol Venereol. 2016 Aug;151(4):436-40. Epub 2014 Jul 11.
10
Case series showing the efficacy of 5-aminolaevulinic acid photodynamic therapy for epidermal growth factor receptor inhibitor-induced paronychia and pyogenic granuloma-like lesions.
Br J Dermatol. 2019 Mar;180(3):676-677. doi: 10.1111/bjd.17270. Epub 2018 Nov 29.

引用本文的文献

1
Ingrown Finger Nail-A Lesser Known Entity.嵌甲——一个鲜为人知的病症。
J Cutan Aesthet Surg. 2023 Apr-Jun;16(2):152-153. doi: 10.4103/JCAS.JCAS_125_22.
2
An Innovative Treatment for Grade 1 Stage of Ingrown Fingernail.
Indian Dermatol Online J. 2021 Jun 21;12(5):778-779. doi: 10.4103/idoj.IDOJ_763_20. eCollection 2021 Sep-Oct.